Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
Silence Therapeutics Plc (SLN)
Silence Therapeutics - Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
SILENCE THERAPEUTICS PLC (SLN)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
ERASCA, INC. (ERAS)
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SEPTERNA, INC. (SEPN)
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
INSPIREMD, INC. (NSPR)
InspireMD to Announce Second Quarter 2026 Financial Results
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
ALPHA TAU MEDICAL LTD. (DRTS)
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
MY SIZE, INC. (MYSZ)
MySize Announces Reverse Stock Split